Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
JD Health International, Inc. ( (HK:6618) ) just unveiled an announcement.
JD Health International Inc. has announced the composition of its board of directors, which includes executive, non-executive, and independent non-executive directors. The board is structured with three committees: audit, remuneration, and nomination, each with designated chairpersons and members. This announcement underscores the company’s commitment to robust governance and strategic oversight, potentially impacting its operational efficiency and stakeholder confidence.
The most recent analyst rating on (HK:6618) stock is a Buy with a HK$78.50 price target. To see the full list of analyst forecasts on JD Health International, Inc. stock, see the HK:6618 Stock Forecast page.
More about JD Health International, Inc.
JD Health International Inc. is a company incorporated in the Cayman Islands, primarily operating in the healthcare industry. It provides a range of health-related services and products, focusing on leveraging technology to enhance healthcare delivery.
Average Trading Volume: 9,992,197
Technical Sentiment Signal: Buy
Current Market Cap: HK$206.5B
For a thorough assessment of 6618 stock, go to TipRanks’ Stock Analysis page.